Executive remuneration in Australia’s health care and biotechnology sectors rose modestly in the last financial year, with a 7.2 per cent increase in total CEO pay, according to the 2025 ASX Health Care and Biotechnology Remuneration Report.
CEO pay rebounds across ASX health and biotech as boards balance pressure and retention
December 3, 2025 Australian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
Queensland cardiac experts back a new plan to stop the second heart attack
September 18, 2026 - - Latest News -
We have one of Australia's answers to 'MFN' and people will die as a result
September 18, 2026 - - Latest News -
Is the fairest part of our medicines access system delivered overseas?
September 18, 2026 - - Latest News -
Mayne Pharma bets on an untapped corner of the menopause market
September 17, 2026 - - Latest News -
Genomic testing to reach more patients with hard to treat cancers
September 17, 2026 - - Latest News -
Eight women named finalists for 2026 Marie Krogh Young Women in Science Prize
September 17, 2026 - - Latest News -
'Your success makes you a target and take it as a compliment'
September 16, 2026 - - Latest News
